Biomarkers of Cardiovascular Risk: State of the Art

Biomarkers of Cardiovascular Risk

October 30-31, 2007

Contact Information

Mayo Medical Laboratories
Education Department

E-Mail Address
Phone: 800.533.1710
Fax: 507.284.8016
Global: 507.284.3156

Biomarkers of Cardiovascular Risk:
State of the Art

Conference Agenda

Print Page Email Page

Tuesday, October 30, 2007

Noon

Registration

Foyer, Leighton Auditorium – 2nd Fl., Harold W. Siebens Medical Education Bldg
12:50 PM

Opening Remarks

David L. Hayes, MD – Chair, Division of Cardiovascular Diseases

 

Session I: Imaging and Arterial Function
Session Chair: Thomas C. Gerber, MD, PhD, FACP, FACC, FAHA

1:00 PM Keynote Address - Early Atherosclerosis
and Prevention – The New Frontiers of Health Care
Raymond J. Gibbons, MD
This portion of the conference will be in conjunction with the Putting Prevention into Practice: Preventing Cardiovascular Diseases in the Clinical Setting conference held October 29-30.
1:25 PM Arterial Stiffness, Wave Reflections, and
Inflammatory Factors
Michel E. Safar, MD
1:50 PM Computed Tomography
John A. Rumberger, PhD, MD, FACC
2:15 PM MRI of Atherosclerotic Plaque
Christopher M. Kramer, MD
2:40 PM Panel Discussion
3:10 PM Break

 

Session II: NHLBI Clinical Proteomics Program
Session Chair: Pothur R. Srinivas, PhD, MPH

3:25 PM NHLBI Clinical Proteomics Initiative
Pothur R. Srinivas, PhD, MPH
3:35 PM Markers of Pulmonary Hypertension
Frank J. Accurso, MD
3:50 PM Markers of Myocardial Damage
Robert E. Gerszten, MD / Marc S. Sabatine, MD, MPH
4:10 PM Vascular Proteomics
Iftikhar J. Kullo, MD
4:25 PM Markers of Lung Injury
Lorraine B. Ware, MD
4:40 PM Panel Discussion
5:10 PM Adjourn
6:00 PM Conference Dinner
Elizabethan Room – The Kahler Grand Hotel

 

Wednesday, October 31, 2007

7:00 AM Breakfast
Foyer, Leighton Auditorium – 2nd Fl., Harold W. Siebens Medical Education Bldg
7:50 AM Opening Remarks
Franklin R. Cockerill III, MD, Chair, Department of Laboratory Medicine and Pathology and President, Mayo Collaborative Services

 

Session III: Atherosclerosis Biology and “omic” Markers
Session Chair: Iftikhar J. Kullo, MD

8:00 AM Atherosclerotic Plaque Biology
Renu Virmani, MD
8:25 AM Genetic Markers of Vascular Disease
Teri Manolio, MD, PhD
8:50 AM Circulating Progenitor Cells
Robert D. Simari, MD
9:15 AM Panel Discussion
9:45 AM Break

 

Session IV: Novel Markers
Session Chair: John C. Burnett, MD

 

10:00 AM PAPP-A
Cheryl A. Conover, PhD
10:20 AM Lipoprotein Associated Phospholipase A2: A Risk Marker for Cardiovascular Disease and a Potential Therapeutic Target
Joseph P. McConnell, PhD
10:40 AM Natriuretic Peptides
John C. Burnett, MD
11:00 AM Proteomic Markers of Vulnerable Plaque
Jennifer Van Eyk, PhD
11:20 AM Panel Discussion
11:50 AM Lunch
Marriott Ballroom

 

Session V: Informatics, Statistics
Session Chair: Paul M. Ridker, MD

1:00 PM Informatics and Assay Validation
George G. Klee, MD, PhD
1:20 PM Statistical Approaches to Evaluating Biomarkers
Nancy R. Cook, ScD
1:40 PM New Risk Prediction Algorithms
Paul M. Ridker, MD
2:00 PM Panel Discussion
2:30 PM Break

 

Session VI: Industry and Regulatory Perspective
Session Chair: George G. Klee, MD, PhD

2:45 PM Biomarkers in Drug Development
Mehmood Khan, MD, FACE
3:05 PM FDA and Multiplex Panels
Steven I. Gutman, MD, MBA
3:25 PM National Institutes of Standards and Technology: Activities for Improving Assay Harmonization
Willie E. May, PhD
3:45 PM Panel Discussion

 

Session VII: New Technologies
Session Chair: George G. Klee, MD, PhD

4:00 PM Nanotechnology
Fred E. Regnier, MD
4:20 PM Mass Spectrometry in Biomarker Discovery and Analysis
Glen L. Hortin, MD, PhD
4:40 PM BeadXpress Platform
John A. Moon, PhD
5:00 PM Panel Discussion
5:15 PM Adjourn

 

Key